The Children's Adaptive Deep Brain Stimulation for Epilepsy Trial
Recruiting now · Not applicable
Conditions studied: Lennox Gastaut Syndrome (LGS)
In brief
The CADET Trial will investigate the effectiveness of deep brain stimulation (DBS) to reduce the frequency of seizures in children with Lennox-Gastaut syndrome (LGS). The CADET Trial will use a non-CE/UKCA marked device - the Picostim DBS system. The SMART-DBS study is a sub-study of the CADET Trial. SMART-DBS will investigate the application of adaptive DBS for the treatment of children with LGS. Children will be recruited after they exit from either the prior 'CADET Pilot Study' or 'CADET Trial' - meaning that these children will already be receiving therapy with an already implanted Picostim device.
Key facts
- Study ID
- NCT06924086
- Run by
- University College, London
- People needed
- 22
- Starts
- 2026-03-24
- Expected to finish
- 2028-01-31
- Last updated by the study team
- 2026-04-07
Who can join
Age: 5 and older, up to 14. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Great Ormond Street Hospital NHS Foundation Trust — London, United Kingdom (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.